HemostOD partners with the biggest transfusion service in Switzerland

The Swiss preclinical biotech company HemostOD and Interregional Blood Transfusion SRC, the biggest Swiss blood transfusion services, are pleased to announce their partnership to collaborate on the in vitro production of platelets. The collaboration will empower the development from bioreactor to patients. In vitro production of blood cells (i.e. in bioreactor) has emerged during the […]

Partnering with the Swiss Biotech Center

HemostOD partners with the Swiss Biotech Center to pre-industrialize its technology. Thanks to this new partnership HemostOD will benefit from solid expertise and state-of-the-art infrastructure in bioprocess engineering. Link to the press release

Tech Seed loan

HemostOD receives a loan of CHF 100’000 from the Foundation for Technological Innovation (FIT).

Seed Round

HemostOD raises CHF 1.7M in seed round financing.

Venture Kick II

HemostOD wins Venture Kick’s second stage of financial (CHF 40’000) and entrepreneurial support. Link to Venture Kick Programme

Venture Kick I

HemostOD receives the support of Venture Kick’s first stage (CHF 10’000). Link to Venture Kick Programme